Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [8204]

Researchers identify target to overcome treatment resistance in preclinical models of KRAS-mutant cancers

Researchers identify target to overcome treatment resistance in preclinical models of KRAS-mutant cancers

New organ-on-a-chip platform allows the testing of cancer vaccine efficacy in ageing populations

New organ-on-a-chip platform allows the testing of cancer vaccine efficacy in ageing populations

A starting point for the development of new pain and cancer drugs

A starting point for the development of new pain and cancer drugs

From lab to clinic: Phase 1 clinical trial of promising combination therapy for resistant ovarian cancer

From lab to clinic: Phase 1 clinical trial of promising combination therapy for resistant ovarian cancer

Pathway discovered to make the most common breast cancer tumour responsive to immunotherapy

Pathway discovered to make the most common breast cancer tumour responsive to immunotherapy

Breast cancer remodels lymphatic vessels to accelerate its spreading

Breast cancer remodels lymphatic vessels to accelerate its spreading

Identifying genes that keep cancer from spreading

Identifying genes that keep cancer from spreading

Researchers suppresses side effects of mRNA therapeutics, broadly applicable platform for safer, personalised treatments

Researchers suppresses side effects of mRNA therapeutics, broadly applicable platform for safer, personalised...

FDA approves epcoritamab-bysp for follicular lymphoma indications

FDA approves epcoritamab-bysp for follicular lymphoma indications

FDA approves selumetinib for adults with neurofibromatosis type 1 with symptomatic, inoperable plexiform neurofibromas

FDA approves selumetinib for adults with neurofibromatosis type 1 with symptomatic, inoperable plexiform...

More from ecancer